These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8139785)

  • 61. [Endometrial hyperplasia--diagnosis and treatment].
    Tropé CG; Marth C; Scheistrøen M; Abeler VM
    Tidsskr Nor Laegeforen; 1999 May; 119(14):2030-4. PubMed ID: 10394278
    [TBL] [Abstract][Full Text] [Related]  

  • 62. High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines.
    Emons G; Schröder B; Ortmann O; Westphalen S; Schulz KD; Schally AV
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1458-64. PubMed ID: 8263128
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of treatment with cyproterone acetate on uterine bleeding at the beginning of GnRH analogue therapy in girls with idiopathic central precocious puberty.
    Seminara S; Nanni L; Generoso M; Mirri S; Leonardi V; Slabadzianiuk T; Vetrano ML; Buongiorno A; Losi S; Galluzzi F
    Horm Res Paediatr; 2010; 73(5):386-9. PubMed ID: 20389110
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Balloon thermoablation in a woman with complex endometrial hyperplasia with atypia. A case report.
    Minassian VA; Mira JL
    J Reprod Med; 2001 Oct; 46(10):933-6. PubMed ID: 11725742
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [THe use of leuprolide in endometrial glandular hyperplasia].
    Menozzi G; Gozzi M; Greci P; Straticò G; Talarico G
    Minerva Ginecol; 1992; 44(7-8):383-6. PubMed ID: 1407643
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Use of a GnRH analogue in the treatment of certain forms of endometrial hyperplasia associated with menometrorrhagia].
    Bonfirraro G; Sanna B; De Marco A; Chieffi O; Bonfirraro PP; Orlando V
    Minerva Ginecol; 1995 Oct; 47(10):467-70. PubMed ID: 8559438
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Regression of endometrial hyperplasia after treatment with the gonadotrophin-releasing hormone analogue triptorelin: a prospective study.
    Grimbizis G; Tsalikis T; Tzioufa V; Kasapis M; Mantalenakis S
    Hum Reprod; 1999 Feb; 14(2):479-84. PubMed ID: 10099998
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Treatment of hyperplasia endometrium with GNRH agonists].
    Radowicki S; Skórzewska K
    Ginekol Pol; 2003 Sep; 74(9):836-9. PubMed ID: 14674133
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Therapy of simple endometrial hyperplasia with GnRH analogs. Evaluation of a multicentric ambulatory study. Preliminary results].
    Zagni R; Cortelazzi R; Cipolla L; Giannetta G; Ferrante B; Soliani A
    Minerva Ginecol; 1993 Dec; 45(12):597-602. PubMed ID: 8139785
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
    Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
    Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Endometriosis].
    Osuga Y
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():112-5. PubMed ID: 16689294
    [No Abstract]   [Full Text] [Related]  

  • 72. Optimal management of endometrial hyperplasia.
    Marsden DE; Hacker NF
    Best Pract Res Clin Obstet Gynaecol; 2001 Jun; 15(3):393-405. PubMed ID: 11476561
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Current possibilities of examination and preservative treatment in endometrial hyperplasia].
    Kołodziejczak M; Knapp P; Kuźmicki M; Knapp P
    Ginekol Pol; 2011 Jul; 82(7):514-9. PubMed ID: 21913429
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Triptorelin in the management of prostate cancer.
    Ploussard G; Mongiat-Artus P
    Future Oncol; 2013 Jan; 9(1):93-102. PubMed ID: 23252566
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.